Dr John Ray Bilello, OD in Galliano, LA - Optometrist

Dr John Ray Bilello, OD is a Optometrist based in Galliano, Louisiana. Dr John Ray Bilello is licensed to practice in Louisiana (license number 774-212T) and his current practice location is 16759 Highway 3235, Store 502, Galliano, Louisiana. He can be reached at his office (for appointments etc.) via phone at (985) 632-4747.

NPI number for Dr John Ray Bilello is 1275623712 and his current mailing address is 524 Blake Ct, Thibodaux, Louisiana. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1275623712.

Contact Information

	Dr John Ray Bilello, OD
	16759 Highway 3235, Store 502, Galliano, LA 70354
	(985) 632-4747
	Not Available

Healthcare Provider's Profile

Full Name	Dr John Ray Bilello
Gender	Male
Speciality	Optometrist
Location	16759 Highway 3235, Galliano, Louisiana
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1275623712
Provider Enumeration Date: 10/13/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr John Ray Bilello such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1275623712	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	774-212T (Louisiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr John Ray Bilello is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr John Ray Bilello, OD 524 Blake Ct, Thibodaux, LA 70301-3504 Ph: () -	Dr John Ray Bilello, OD 16759 Highway 3235, Store 502, Galliano, LA 70354 Ph: (985) 632-4747

News Archive

Novel method sheds light on how disruption in LRRK2 gene causes inherited Parkinson's disease

Scientists have developed a new method of measuring the activity of disease-causing mutations in the LRRK2 gene, a major cause of inherited Parkinson's disease.

Researchers investigate effects of non-allergenic components of pollen on allergy sufferers

Up to now, research into pollen allergies has largely focused on allergens - those components of pollen that trigger hypersensitivity reactions. When it comes into contact with the nasal mucous membrane, however, pollen releases a host of other substances in addition to allergens.

Orgenesis receives €2.015 million grant to develop potential cure for Type 1 Diabetes

Orgenesis SPRL, a subsidiary of Orgenesis Inc., a leader in the emerging fields of cellular therapy and regenerative medicine, today announced that it has received the formal approval from the Walloon Region, Belgium (Service Public of Wallonia, DG06) for a €2.015 million support program for the research and development of a potential cure for Type 1 Diabetes.

ActiveCare announces availability of new line of services for aging individuals

ActiveCare Inc. today announced the availability of a new line of services that provide aging individuals and their caregivers many conveniences similar to those offered by in-home care or assisted living, only at the touch of a button and at a fraction of the cost.

More opinions: Berwick, Deparle, Rep. Pitts and others on health costs; public health transparency guidelines

Unfortunately, there are too many examples that show how our system can fail to meet patients' needs. These problems are not a reflection on the many doctors, nurses and other professionals who work tirelessly to deliver the highest quality care they can.

Dr John Ray Bilello, OD - Optometrist in Galliano, LA